Výsledky vyhledávání - "J Karankumar"

Akademický článek

Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study

Autor: K Krishnaprasad, P Manshani, J Karankumar

Publikováno v: Perspectives in Clinical Research, Vol 3, Iss 2, Pp 62-65 (2012)

To assess the likely impact of a fixed dose combination (FDC) of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine on the health outcome and safety profile arising from the complementary action of amantadine and other ingredients,

Externí odkaz: https://doaj.org/article/2f514541a81c44959e362e4ad5ffe1e9

Zobrazit plný text záznamu

Intensive dose of rosuvastatin (40 mg/day), initiated early and continued for 12 weeks, in ‘very high’ risk or ‘high’ risk Indian patients

Autor: S. Suryawanshi, J. Karankumar, Sameer Dani, B.B. Chanana, P. Moorthy, C.P. Shah, N.C. Krishnamani, S.S. Lakshmanan, B.P. Shah, G.P. Ratnaparkhi, Ashwani Mehta, K.M.K. Reddy, M.S.S. Mukharjee

Publikováno v: Indian Heart Journal, Vol 66, Iss S2, Pp S28-S29 (2014)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8d73a4f1a69f1da25294cc0304fd517
https://doi.org/10.1016/j.ihj.2014.10.080

Zobrazit plný text záznamu

Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study

Autor: J Karankumar, P Manshani, K Krishnaprasad

Publikováno v: Perspectives in Clinical Research
Perspectives in Clinical Research, Vol 3, Iss 2, Pp 62-65 (2012)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffe6a2eaf467d38196a9810dbe6a7cbe
https://doi.org/10.4103/2229-3485.96447

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Intensive dose of rosuvastatin (40 mg/day), initiated early and continued for 12 weeks, in ‘very high’ risk or ‘high’ risk Indian patients

Autor: C.P. Shah, B.P. Shah, N.C. Krishnamani, A. Mehta, P. Moorthy, G.P. Ratnaparkhi, S. Dani, S.S. Lakshmanan, M.S.S. Mukharjee, K.M.K. Reddy, B.B. Chanana, S. Suryawanshi, J. Karankumar

Publikováno v: Indian Heart Journal, Vol 66, Iss S2, Pp S28-S29 (2014)

Externí odkaz: https://doaj.org/article/35741814d9634218998bf2192e0e9941

Zobrazit plný text záznamu

Akademický článek

Health outcome and safety assessment of a fixed dose combination of Amantadine, Paracetamol, Chlorpheniramine maleate, and Phenylephrine introduction in India: A prescription event monitoring study.

Autor: Krishnaprasad K; Glenmark Pharmaceuticals Ltd, Corporate Enclave, Mumbai, India., Manshani P, Karankumar J

Publikováno v: Perspectives in clinical research [Perspect Clin Res] 2012 Apr; Vol. 3 (2), pp. 62-5.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání